Abstract
The aim of this paper is to review the antimicrobial activity of thiourea derivatives against planktonic and adherent bacterial and fungal strains, as well as to show how nanotechnology could improve the intrinsic antimicrobial activity of the novel substances, by obtaining biocompatible nanocomposites based on magnetite nanoparticles and newly synthesized 2-((4-ethylphenoxy)methyl)-N- (alkylphenylcarbamothioyl) benzamides, which proved increased resistance to microbial colonization or inhibited the development of already existent biofilms, revealing a great potential for biomedical applications.
Keywords: Benzamides, Thiourea derivatives, Magnetic nanoparticles, Anti-biofilm properties, Quorum sensing inhibitors
Current Organic Chemistry
Title:Antimicrobial Potential of Benzamides and Derived Nanosystems for Controlling in vitro Biofilm Development on Medical Devices
Volume: 17 Issue: 2
Author(s): Carmen Limban, Alexandru Mihai Grumezescu, Mariana Chirea, Lilia Matei and Mariana Carmen Chifiriuc
Affiliation:
Keywords: Benzamides, Thiourea derivatives, Magnetic nanoparticles, Anti-biofilm properties, Quorum sensing inhibitors
Abstract: The aim of this paper is to review the antimicrobial activity of thiourea derivatives against planktonic and adherent bacterial and fungal strains, as well as to show how nanotechnology could improve the intrinsic antimicrobial activity of the novel substances, by obtaining biocompatible nanocomposites based on magnetite nanoparticles and newly synthesized 2-((4-ethylphenoxy)methyl)-N- (alkylphenylcarbamothioyl) benzamides, which proved increased resistance to microbial colonization or inhibited the development of already existent biofilms, revealing a great potential for biomedical applications.
Export Options
About this article
Cite this article as:
Limban Carmen, Mihai Grumezescu Alexandru, Chirea Mariana, Matei Lilia and Carmen Chifiriuc Mariana, Antimicrobial Potential of Benzamides and Derived Nanosystems for Controlling in vitro Biofilm Development on Medical Devices, Current Organic Chemistry 2013; 17 (2) . https://dx.doi.org/10.2174/1385272811317020013
DOI https://dx.doi.org/10.2174/1385272811317020013 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Impact of Anabolic Androgenic Steroids on Neuropeptide Systems
Mini-Reviews in Medicinal Chemistry Medical Applications of Hyperthermia Based on Magnetic Nanoparticles
Recent Patents on Biomedical Engineering (Discontinued) Aptamers as Targeting Delivery Devices or Anti-cancer Drugs for Fighting Tumors
Current Drug Metabolism Altered Hyaluronan Biosynthesis and Cancer Progression: an Immunological Perspective
Mini-Reviews in Medicinal Chemistry Adipose Stem Cells and Skin Repair
Current Stem Cell Research & Therapy Recent Approaches to Improve the Antitumor Efficacy of Temozolomide
Current Medicinal Chemistry Editorial (Thematic Issue: From Nuisance to State-of-the-Art: FDG-PET/CT Imaging of Infection and Inflammation)
Current Molecular Imaging (Discontinued) Possible Involvement of Muscarinic Receptors in Psychiatric Disorders: A Focus on Schizophrenia and Mood Disorders
Current Molecular Medicine Alterations in Glucose Metabolism in Alzheimer's Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Isolation and Characterization of a Lectin from Japanese Mottled Beans
Protein & Peptide Letters Liver and Pancreatic Disease in Cystic Fibrosis: Clinics and Drug Therapy
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) The Cross-over of Anticancer Agents with Osteoclast Activities
Current Cancer Therapy Reviews Ethical and Social Issues in Pharmacogenomics Testing
Current Pharmaceutical Design FAK and p53 Protein Interactions
Anti-Cancer Agents in Medicinal Chemistry Anti-adipogenic and Cytotoxic Effects of a New Compound from <i>Hartmannia rosea</i> G. Don
Current Pharmaceutical Analysis Diosmetin, a Potential p53 Activator, Performs Anticancer Effect by Regulating Cell Cycling and Cell Proliferation in HepG2 Cells
Protein & Peptide Letters Meet Our Editorial Board Member
Current Nanomedicine A Brief Review on Breast Carcinoma and Deliberation on Current Non Invasive Imaging Techniques for Detection
Current Medical Imaging Synthesis of Some Benzimidazole-derived Molecules and their Effects on PARP-1 Activity and MDA-MB-231, MDA-MB-436, MDA-MB-468 Breast Cancer Cell Viability
Anti-Cancer Agents in Medicinal Chemistry Breast Cancer: Not Only a “Womans” Disease
Current Women`s Health Reviews